Clinical Trial

Fospropofol Disodium ED95 for Elderly Spinal Anesthesia Sedation

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This study aims to determine the 95% effective dose (ED95) of fospropofol disodium, a new sedative drug, for adjuvant sedation during spinal anesthesia in elderly patients (aged 65 years and older) undergoing lower extremity surgery (e.g., hip/knee replacement, lower limb fracture fixation).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-31.
Trial Details
NCT Number NCT07333508
Lead Sponsor Ya-Qun Zhou
Conditions Lower Extremity Surgery
Enrollment 60 participants
Start Date 2026-01-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-03-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-13